Home › Funds › Burkehill Global Management, LP › BBIO

Burkehill Global Management, LP position in BBIO

BRIDGEBIO PHARMA INC · Health Care

Burkehill Global Management, LP reported holding 100,000 shares of BBIO (BRIDGEBIO PHARMA INC) in its Q3 2026 13F filing — a position valued at US$6.6M, representing 0.29% of its reported portfolio and ranking #44 among its reported holdings. Burkehill Global Management, LP has disclosed BBIO holdings in 3 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)100.00K sh
Reported value held$6.58M
Portfolio Weight0.29%
First reportedQ2 2025
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Burkehill Global Management, LP's BBIO position evolved

Burkehill Global Management, LP first disclosed a stake in BBIO in Q2 2025 at 275,000 shares (US$11.9M). The position peaked in Q3 2025 at 275,000 shares, worth US$14.3M. Across 3 filings, Burkehill Global Management, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 100,000 shares valued at US$6.6M.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 275.00K $11.87M New
Q3 2025 275.00K $14.28M Hold
Q3 2026 100.00K $6.58M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BBIO and 13F data

BBIO (BRIDGEBIO PHARMA INC) is a Health Care company. 40 other funds we track also report a position in BBIO — the largest reported positions include Jupiter Topco LLC (US$1.05B), Janus Henderson Group (US$957.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$937.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BBIO

All BBIO fund holders →

FAQ

How long has Burkehill Global Management, LP held BBIO?

Burkehill Global Management, LP has disclosed BBIO holdings in 3 of the last 6 reported quarters, going back to Q2 2025.

What is Burkehill Global Management, LP's current position in BBIO?

As of Q3 2026, Burkehill Global Management, LP holds 100.00K shares of BBIO (BRIDGEBIO PHARMA INC), valued at $6.58M, representing 0.29% of its reported portfolio and ranking #44.

Has Burkehill Global Management, LP been buying or selling BBIO?

In the latest 13F filing (Q3 2026), Burkehill Global Management, LP newly opened its position in BBIO. The position peaked in Q3 2025 at 275.00K shares.

Which other funds hold BBIO?

Other major institutional holders of BBIO include Jupiter Topco LLC, Janus Henderson Group, FARALLON CAPITAL MANAGEMENT, L.L.C., among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.